Grace Therapeutics, Inc. Repayments of Convertible Debt
Grace Therapeutics, Inc. (GRCE) reported Repayments of Convertible Debt of $1.56 million for the 3-month period ending 2020-03-31, per its 10-K filed 2020-06-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2021-06-22
- Grace Therapeutics, Inc. repayments of convertible debt for fiscal 2020 was 2.00M CAD.
CAD
| Period end | Repayments of Convertible Debt 12 month |
|---|---|
| 2020-03-31 | 2.00M CAD 10-K · filed 2020-06-29 |
USD
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 12 month |
|---|---|---|
| 2020-03-31 | $1.56M 10-K · filed 2020-06-29 | $1.56M 10-K · filed 2021-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |